Cite
HARVARD Citation
Nader, M. et al. (2017). Sudden hearing loss in a melanoma patient on pembrolizumab: an etiology not to be omitted in the differential diagnosis. Journal for immunotherapy of cancer. 5 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nader, M. et al. (2017). Sudden hearing loss in a melanoma patient on pembrolizumab: an etiology not to be omitted in the differential diagnosis. Journal for immunotherapy of cancer. 5 (1), p. . [Online].